Comparison · NCT01205776-a8b00e0f
Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Thrombolysis in Myocardial Infarction (TIMI) Major or Minor Bleeding
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Percutaneous Coronary Intervention (PCI) vs Coronary Artery Bypass Graft (CABG): Number of Participants With Thrombolysis in Myocardial Infarction (TIMI) Major or Minor Bleeding. Trial comparisons, record NCT01205776-a8b00e0f. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01205776-a8b00e0f
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0369 | 0.0267 | 0.0509 | wilson | |
| Risk in group 2 | 0.0888 | 0.0724 | 0.109 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0519 | -0.0741 | -0.0303 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.416 | 0.283 | 0.61 | log | |
| Odds ratio, group 1 over group 2 | 0.393 | 0.262 | 0.589 | log | |
| Number needed to treat, for one fewer participant with the outcome on Percutaneous Coronary Intervention (PCI) than on Coronary Artery Bypass Graft (CABG) | 19.3 | 13.5 | 33 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Percutaneous Coronary Intervention (PCI) | Those patients receiving the XIENCE PRIME™ EECSS or XIENCE V® EECSS or XIENCE Xpedition™ EECSS or XIENCE PRO EECSS | 35 | 948 | OG000 |
| Group 2 | Coronary Artery Bypass Graft (CABG) | Those patients receiving Coronary Artery Bypass Graft (CABG) | 85 | 957 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With Thrombolysis in Myocardial Infarction (TIMI) Major or Minor Bleeding
- Description
Bleeding will be classified by the TIMI hemorrhage classification~Severity:~Major:~* Intracranial hemorrhage~* A ≥5 g/dL decrease in the hemoglobin concentration~* A ≥15% absolute decrease in the hematocrit~Minor:~* Observed blood loss:~ * A ≥ 3 g/dL decrease in the hemoglobin concentration~ * A ≥ 10% absolute decrease in the hematocrit~* No observed blood loss:~ * A ≥ 4 g/dL decrease in the hemoglobin concentration~ * A ≥ 12% absolute decrease in the hematocrit~Minimal:~• Any clinically overt sign of hemorrhage (including imaging) that is associated with a \< 3 g/dL decrease in hemoglobin concentration or \< 9% decrease in the hematocrit.
- Time frame
- 30 days
- Population
- ITT population. Analysis population includes subjects who had follow-up data at that time period.
Source ClinicalTrials.gov
Trial
- Title
- EXCEL Clinical Trial
- NCT number
- NCT01205776
- Phases
- NA
- Conditions
Chronic Coronary Occlusion, Unprotected Left Main Coronary Artery Disease, Stent Thrombosis, Vascular Disease, Myocardial Ischemia, Coronary Artery Stenosis, Coronary Disease, Coronary Artery Disease, Coronary Restenosis
- Interventions
- Percutaneous Coronary Intervention, CABG
- Lead sponsor
- Abbott Medical Devices
- Results first posted
- 2018-03-29
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01205776?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01205776-a8b00e0f